Edrophonium

ANTICUDE 12,5 mg/ml SOLUCION INYECTABLE

25 mg solución inyectableSpainMarketedAuthorised 31 Oct 1965

In other countries

The same active substances on other registers, the same brand first.

AnyNew Zealand · Inj 10 mg per ml, 15 ml vialSame form
Edrophonium ChlorideUnited States · 10MG/ML · injectable · Watson LabsSame form
Edrophonium Chloride Preservative FreeUnited States · 10MG/ML · injectable · Watson LabsSame form
EnlonUnited States · 10MG/ML · injectable · PharmobedientSame form
Enlon 10MG/MLCanada · 10 MG / ML · Liquid · Baxter CorporationSame substance
Enlon Liq IV 10MG/MLCanada · 10 MG / ML · Liquid · Ohmeda Pharmaceutical Products, Division of Boc Canada LimitedSame substance
TensilonCanada · 10 MG / ML · Liquid · Valeant Canada LP / Valeant Canada S.E.C.Same substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Edrophonium

ANTICUDE 12,5 mg/ml SOLUCION INYECTABLE

25 mg solución inyectableSpainMarketedAuthorised 31 Oct 1965

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Packs

Pack	Code	Status
ANTICUDE 12,5 mg/ml SOLUCION INYECTABLE, 2 ampollas de 2 ml	885764

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Edrophonium
Strength: 25 mg
Dosage form: solución inyectable
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 31 Oct 1965
Registration: 42021
Marketing authorisation holder: Mana Pharma S.L.
Procedure: National, MRP or DCP
Supply: Uso Hospitalario